Intratumoral Application of L19IL2 in Patients With Malignant Melanoma
Clinical trial NCT01253096 · COMPLETED
Trial details
- NCT number
- NCT01253096
- Sponsor
- Philogen S.p.A.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2010-04-01
- Primary completion
- 2013-09-01
- Enrollment
- 25
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.